Kiora Pharma receives Nasdaq non-compliance letter
seekingalpha.com
finance
2022-05-31 21:05:26

Funtap/iStock via Getty Images Kiora Pharma (NASDAQ:KPRX) said it had received a letter from the Nasdaq Stock Market that it was not in compliance with requirements of Nasdaq Listing Rule as it failed to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31 with the Securities and Exchange Commission. The company said it was unable to complete and file the Form 10-Q by the required due date of May 16 as it was preparing the amended Form 10-K for financial year 2021 and 2020.
